USFDA completes inspection of Ajanta Pharma’s facility at Gujarat

27 Jul 2018 Evaluate

US Food and Drug Administration (USFDA) has completed inspection of Ajanta Pharma’s formulation facility at Dahej in the state of Gujarat from July 23-27, 2018. After the inspection, there were no observations found.

Ajanta Pharma is a speciality pharmaceutical formulation company having branded generic business in India and emerging markets, generic business in US and institution business in Africa.


Ajanta Pharma Share Price

2638.75 12.50 (0.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×